Matcare Empagliflozin and linagliptin Tablets.
Empagliflozin and Linagliptin Tablets
Overview
Empagliflozin and linagliptin is a combination medication designed to support blood sugar management in adults with type 2 diabetes mellitus, alongside a healthy diet and regular exercise. Additionally, this medication is prescribed to reduce the risk of fatal cardiovascular events, including heart attack, stroke, or heart failure, in individuals with type 2 diabetes who also have pre-existing heart conditions.
This medication is not intended for the treatment of type 1 diabetes. It may also be used for other medical purposes beyond those outlined in this guide, based on healthcare provider recommendations.
Important Considerations Before Use
Avoid using this medication if you are allergic to empagliflozin or linagliptin, or if you have:
- Severe kidney disease, including those undergoing dialysis
- A history of severe allergic reactions or skin complications related to empagliflozin or linagliptin
- Diabetic ketoacidosis—seek immediate medical attention
Inform your healthcare provider if you have any of the following conditions:
- Liver or kidney disease
- Bladder infections or urinary complications
- Pancreatic disorders
- Heart failure
- Gallstones
- Genital infections (affecting the penis or vagina)
- Alcohol dependency or frequent excessive alcohol consumption
- Adherence to a low-sodium diet
- Age 65 or older
- Scheduled surgical procedures
- High cholesterol or triglycerides
Pregnancy and Breastfeeding
Consult your doctor regarding the use of empagliflozin and linagliptin during pregnancy. Proper diabetes management is essential for maternal and fetal health.
This medication should not be used during the second and third trimesters of pregnancy.
Breastfeeding while taking this medication is not recommended.
